Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?

Background. Neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume-to-platelet count (MPV/PC) ratio are readily available parameters that might have discriminative power regarding outcome. The aim of our study was to ass...

Full description

Bibliographic Details
Main Authors: Dragan Djordjevic, Goran Rondovic, Maja Surbatovic, Ivan Stanojevic, Ivo Udovicic, Tamara Andjelic, Snjezana Zeba, Snezana Milosavljevic, Nikola Stankovic, Dzihan Abazovic, Jasna Jevdjic, Danilo Vojvodic
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2018/3758068
id doaj-09559c9b94b1466aaa89839fe8b31bc9
record_format Article
spelling doaj-09559c9b94b1466aaa89839fe8b31bc92020-11-25T00:09:34ZengHindawi LimitedMediators of Inflammation0962-93511466-18612018-01-01201810.1155/2018/37580683758068Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?Dragan Djordjevic0Goran Rondovic1Maja Surbatovic2Ivan Stanojevic3Ivo Udovicic4Tamara Andjelic5Snjezana Zeba6Snezana Milosavljevic7Nikola Stankovic8Dzihan Abazovic9Jasna Jevdjic10Danilo Vojvodic11Clinic of Anesthesiology and Intensive Therapy, Military Medical Academy, Crnotravska 17, 11000 Belgrade, SerbiaClinic of Anesthesiology and Intensive Therapy, Military Medical Academy, Crnotravska 17, 11000 Belgrade, SerbiaClinic of Anesthesiology and Intensive Therapy, Military Medical Academy, Crnotravska 17, 11000 Belgrade, SerbiaFaculty of Medicine, Military Medical Academy, University of Defence, Crnotravska 17, 11000 Belgrade, SerbiaClinic of Anesthesiology and Intensive Therapy, Military Medical Academy, Crnotravska 17, 11000 Belgrade, SerbiaInstitute of Medical Biochemistry, Military Medical Academy, Crnotravska 17, 11000 Belgrade, SerbiaClinic of Anesthesiology and Intensive Therapy, Military Medical Academy, Crnotravska 17, 11000 Belgrade, SerbiaDepartment of Anesthesiology, Clinical Hospital Center Kosovska Mitrovica, Anri Dinana bb, 38220 Kosovska Mitrovica, SerbiaDepartment of Anesthesiology and Intensive Therapy, Mother and Child Health Care Institute of Serbia, Radoja Dakica 8, 11000 Belgrade, SerbiaEmergency Medical Center of Montenegro, Vaka Djurovica bb, 81000 Podgorica, MontenegroClinical Center Kragujevac, Zmaj Jovina 30, 34000 Kragujevac, SerbiaFaculty of Medicine, Military Medical Academy, University of Defence, Crnotravska 17, 11000 Belgrade, SerbiaBackground. Neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume-to-platelet count (MPV/PC) ratio are readily available parameters that might have discriminative power regarding outcome. The aim of our study was to assess prognostic value of these biomarkers regarding outcome in critically ill patients with secondary sepsis and/or trauma. Methods. A total of 392 critically ill and injured patients, admitted to surgical ICU, were enrolled in a prospective observational study. Leukocyte and platelet counts were recorded upon fulfilling Sepsis-3 criteria and for traumatized Injury Severity Score > 25 points. Patients were divided into four subgroups: peritonitis, pancreatitis, trauma with sepsis, and trauma without sepsis. Results. NLR and MPV/PC levels were significantly higher in nonsurvivors (AUC/ROC of 0.681 and 0.592, resp., in the peritonitis subgroup; 0.717 and 0.753, resp., in the pancreatitis subgroup); MLR and PLR did not differ significantly. There was no significant difference of investigated biomarkers between survivors and nonsurvivors in trauma patients with and without sepsis except for PLR in the trauma without sepsis subgroup (significantly higher in nonsurvivors, AUC/ROC of 0.719). Independent predictor of lethal outcome was NLR in the whole cohort and in the peritonitis subgroup as well as MPV in the pancreatitis subgroup. Also, there were statistically significant differences in MPV/PC, MLR, and PLR values regarding nature of bacteremia. In general, the lowest levels had been found in patients with Gram-positive blood cultures. Conclusions. NLR and MPV were very good independent predictors of lethal outcome. For the first time, we demonstrate that nature of bacteremia influences MPV/PC, MLR, and PLR. In heterogeneous cohort subgroup, analysis is essential.http://dx.doi.org/10.1155/2018/3758068
collection DOAJ
language English
format Article
sources DOAJ
author Dragan Djordjevic
Goran Rondovic
Maja Surbatovic
Ivan Stanojevic
Ivo Udovicic
Tamara Andjelic
Snjezana Zeba
Snezana Milosavljevic
Nikola Stankovic
Dzihan Abazovic
Jasna Jevdjic
Danilo Vojvodic
spellingShingle Dragan Djordjevic
Goran Rondovic
Maja Surbatovic
Ivan Stanojevic
Ivo Udovicic
Tamara Andjelic
Snjezana Zeba
Snezana Milosavljevic
Nikola Stankovic
Dzihan Abazovic
Jasna Jevdjic
Danilo Vojvodic
Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?
Mediators of Inflammation
author_facet Dragan Djordjevic
Goran Rondovic
Maja Surbatovic
Ivan Stanojevic
Ivo Udovicic
Tamara Andjelic
Snjezana Zeba
Snezana Milosavljevic
Nikola Stankovic
Dzihan Abazovic
Jasna Jevdjic
Danilo Vojvodic
author_sort Dragan Djordjevic
title Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?
title_short Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?
title_full Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?
title_fullStr Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?
title_full_unstemmed Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?
title_sort neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume-to-platelet count ratio as biomarkers in critically ill and injured patients: which ratio to choose to predict outcome and nature of bacteremia?
publisher Hindawi Limited
series Mediators of Inflammation
issn 0962-9351
1466-1861
publishDate 2018-01-01
description Background. Neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume-to-platelet count (MPV/PC) ratio are readily available parameters that might have discriminative power regarding outcome. The aim of our study was to assess prognostic value of these biomarkers regarding outcome in critically ill patients with secondary sepsis and/or trauma. Methods. A total of 392 critically ill and injured patients, admitted to surgical ICU, were enrolled in a prospective observational study. Leukocyte and platelet counts were recorded upon fulfilling Sepsis-3 criteria and for traumatized Injury Severity Score > 25 points. Patients were divided into four subgroups: peritonitis, pancreatitis, trauma with sepsis, and trauma without sepsis. Results. NLR and MPV/PC levels were significantly higher in nonsurvivors (AUC/ROC of 0.681 and 0.592, resp., in the peritonitis subgroup; 0.717 and 0.753, resp., in the pancreatitis subgroup); MLR and PLR did not differ significantly. There was no significant difference of investigated biomarkers between survivors and nonsurvivors in trauma patients with and without sepsis except for PLR in the trauma without sepsis subgroup (significantly higher in nonsurvivors, AUC/ROC of 0.719). Independent predictor of lethal outcome was NLR in the whole cohort and in the peritonitis subgroup as well as MPV in the pancreatitis subgroup. Also, there were statistically significant differences in MPV/PC, MLR, and PLR values regarding nature of bacteremia. In general, the lowest levels had been found in patients with Gram-positive blood cultures. Conclusions. NLR and MPV were very good independent predictors of lethal outcome. For the first time, we demonstrate that nature of bacteremia influences MPV/PC, MLR, and PLR. In heterogeneous cohort subgroup, analysis is essential.
url http://dx.doi.org/10.1155/2018/3758068
work_keys_str_mv AT dragandjordjevic neutrophiltolymphocyteratiomonocytetolymphocyteratioplatelettolymphocyteratioandmeanplateletvolumetoplateletcountratioasbiomarkersincriticallyillandinjuredpatientswhichratiotochoosetopredictoutcomeandnatureofbacteremia
AT goranrondovic neutrophiltolymphocyteratiomonocytetolymphocyteratioplatelettolymphocyteratioandmeanplateletvolumetoplateletcountratioasbiomarkersincriticallyillandinjuredpatientswhichratiotochoosetopredictoutcomeandnatureofbacteremia
AT majasurbatovic neutrophiltolymphocyteratiomonocytetolymphocyteratioplatelettolymphocyteratioandmeanplateletvolumetoplateletcountratioasbiomarkersincriticallyillandinjuredpatientswhichratiotochoosetopredictoutcomeandnatureofbacteremia
AT ivanstanojevic neutrophiltolymphocyteratiomonocytetolymphocyteratioplatelettolymphocyteratioandmeanplateletvolumetoplateletcountratioasbiomarkersincriticallyillandinjuredpatientswhichratiotochoosetopredictoutcomeandnatureofbacteremia
AT ivoudovicic neutrophiltolymphocyteratiomonocytetolymphocyteratioplatelettolymphocyteratioandmeanplateletvolumetoplateletcountratioasbiomarkersincriticallyillandinjuredpatientswhichratiotochoosetopredictoutcomeandnatureofbacteremia
AT tamaraandjelic neutrophiltolymphocyteratiomonocytetolymphocyteratioplatelettolymphocyteratioandmeanplateletvolumetoplateletcountratioasbiomarkersincriticallyillandinjuredpatientswhichratiotochoosetopredictoutcomeandnatureofbacteremia
AT snjezanazeba neutrophiltolymphocyteratiomonocytetolymphocyteratioplatelettolymphocyteratioandmeanplateletvolumetoplateletcountratioasbiomarkersincriticallyillandinjuredpatientswhichratiotochoosetopredictoutcomeandnatureofbacteremia
AT snezanamilosavljevic neutrophiltolymphocyteratiomonocytetolymphocyteratioplatelettolymphocyteratioandmeanplateletvolumetoplateletcountratioasbiomarkersincriticallyillandinjuredpatientswhichratiotochoosetopredictoutcomeandnatureofbacteremia
AT nikolastankovic neutrophiltolymphocyteratiomonocytetolymphocyteratioplatelettolymphocyteratioandmeanplateletvolumetoplateletcountratioasbiomarkersincriticallyillandinjuredpatientswhichratiotochoosetopredictoutcomeandnatureofbacteremia
AT dzihanabazovic neutrophiltolymphocyteratiomonocytetolymphocyteratioplatelettolymphocyteratioandmeanplateletvolumetoplateletcountratioasbiomarkersincriticallyillandinjuredpatientswhichratiotochoosetopredictoutcomeandnatureofbacteremia
AT jasnajevdjic neutrophiltolymphocyteratiomonocytetolymphocyteratioplatelettolymphocyteratioandmeanplateletvolumetoplateletcountratioasbiomarkersincriticallyillandinjuredpatientswhichratiotochoosetopredictoutcomeandnatureofbacteremia
AT danilovojvodic neutrophiltolymphocyteratiomonocytetolymphocyteratioplatelettolymphocyteratioandmeanplateletvolumetoplateletcountratioasbiomarkersincriticallyillandinjuredpatientswhichratiotochoosetopredictoutcomeandnatureofbacteremia
_version_ 1725411180919390208